Skip to main content

Advertisement

SpringerLink
Log in

Pulmonary Toxicity of Polysorbate-80-coated Inhalable Nanoparticles; In vitro and In vivo Evaluation

  • Brief/Technical Note
  • Published:
The AAPS Journal Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Azarmi S, Roa WH, Lobenberg R. Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Deliv Rev. 2008;60(8):863–75.

    Article  CAS  PubMed  Google Scholar 

  2. Oberdorster G. Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health. 2001;74(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  3. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113(7):823–39.

    Article  CAS  PubMed  Google Scholar 

  4. Muhlfeld C, Rothen-Rutishauser B, Blank F, Vanhecke D, Ochs M, Gehr P. Interactions of nanoparticles with pulmonary structures and cellular responses. Am J Physiol Lung Cell Mol Physiol. 2008;294(5):817–29.

    Article  CAS  Google Scholar 

  5. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2):283–318.

    CAS  PubMed  Google Scholar 

  6. Illum L, Jones PD, Baldwin RW, Davis SS. Tissue distribution of poly(hexyl 2-cyanoacrylate) nanoparticles coated with monoclonal antibodies in mice bearing human tumor xenografts. J Pharmacol Exp Ther. 1984;230(3):733–6.

    CAS  PubMed  Google Scholar 

  7. Araujo L, Lobenberg R, Kreuter J. Influence of the surfactant concentration on the body distribution of nanoparticles. J Drug Target. 1999;6(5):373–85.

    Article  CAS  PubMed  Google Scholar 

  8. Moghimi SM, Hunter AC. Capture of stealth nanoparticles by the body's defences. Crit Rev Ther Drug Carrier Syst. 2001;18(6):527–50.

    CAS  PubMed  Google Scholar 

  9. Alyaudtin RN, Reichel A, Lobenberg R, Ramge P, Kreuter J, Begley DJ. Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro. J Drug Target. 2001;9(3):209–21.

    Article  CAS  PubMed  Google Scholar 

  10. Ku T, Gill S, Lobenberg R, Azarmi S, Roa W, Prenner EJ. Size dependent interactions of nanoparticles with lung surfactant model systems and the significant impact on surface potential. J Nanosci Nanotechnol. 2008;8(6):2971–8.

    Article  CAS  PubMed  Google Scholar 

  11. Gill S, Lobenberg R, Ku T, Azarmi S, Roa W, Prenner EJ. Nanoparticles: characteristics, mechanisms of action, and toxicity in pulmonary drug delivery—a review. J Biomedl Nanotech. 2007;3(2):107–19.

    Article  CAS  Google Scholar 

  12. Smith FB. Role of the pulmonary surfactant system in lung diseases of adults. N Y State J Med. 1983;83(6):851–6.

    CAS  PubMed  Google Scholar 

  13. Schief WR, Antia M, Discher BM, Hall SB, Vogel V. Liquid crystalline collapse of pulmonary surfactant monolayers. Biophys J. 2003;84(6):3792–806.

    Article  CAS  PubMed  Google Scholar 

  14. Stuart D, Lobenberg R, Ku T, Azarmi S, Ely L, Roa W et al. Biophysical investigation of nanoparticle interactions with lung surfactant model systems. J Biomed Nanotech. 2006;2(2–3):245–52.

    Article  CAS  Google Scholar 

  15. Azarmi S, Lobenberg R, Roa WH, Tai S, Finlay WH. Formulation and in vivo evaluation of effervescent inhalable carrier particles for pulmonary delivery of nanoparticles. Drug Dev Ind Pharm. 2008;34(9):943–7.

    Article  CAS  PubMed  Google Scholar 

  16. Sham JO, Zhang Y, Finlay WH, Roa WH, Lobenberg R. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. Int J Pharm. 2004;269(2):457–67.

    Article  CAS  PubMed  Google Scholar 

  17. Azarmi S, Tao X, Chen H, Wang Z, Finlay WH, Lobenberg R et al. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. Int J Pharm. 2006;319(1–2):155–61.

    Article  CAS  PubMed  Google Scholar 

  18. Vauthier C, Labarre D, Ponchel G. Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery. J Drug Target. 2007;15(10):641–63.

    Article  CAS  PubMed  Google Scholar 

  19. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol. 2001;175(3):191–9.

    Article  CAS  PubMed  Google Scholar 

  20. Kodama M, Shibata O, Nakamura S, Lee S, Sugihara G. A monolayer study on three binary mixed systems of dipalmitoyl phosphatidyl choline with cholesterol, cholestanol and stigmasterol. Colloids Surf B Biointerfaces. 2004;33(3–4):211–26.

    Article  CAS  Google Scholar 

Download references

Acknowledgment

This study was supported by a Grant of Alberta Cancer Board. MHD Kamal Al-Hallak acknowledges the receipt of Damascus University scholarship. Shirzad Azarmi acknowledges the receipt of TRTC fellowship from the Alberta Cancer Board.

Author information

Authors and Affiliations

  1. Faculty of Pharmacy and Pharmaceutical Sciences, 3126 Dentistry/Pharmacy Centre, University of Alberta, Edmonton, Alberta, T6G 2N8, Canada

    M. H. D. Kamal Al-Hallak, Shirzad Azarmi & Raimar Löbenberg

  2. Faculty of Pharmacy and Pharmaceutical Sciences, Damascus University, Damascus, Syria

    M. H. D. Kamal Al-Hallak

  3. Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

    Shirzad Azarmi

  4. Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada

    Chris Sun, Patrick Lai & Elmar J. Prenner

  5. Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada

    Wilson H. Roa

Authors
  1. M. H. D. Kamal Al-Hallak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shirzad Azarmi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chris Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrick Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elmar J. Prenner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wilson H. Roa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Raimar Löbenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raimar Löbenberg.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 35 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Hallak, M.H.D.K., Azarmi, S., Sun, C. et al. Pulmonary Toxicity of Polysorbate-80-coated Inhalable Nanoparticles; In vitro and In vivo Evaluation. AAPS J 12, 294–299 (2010). https://doi.org/10.1208/s12248-010-9190-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12248-010-9190-4

Key words

Search

Navigation